Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 21, 2018Frontiers in OncologyOpen Access

Plasticity of Type I Interferon-Mediated Responses in Cancer Therapy: From Anti-tumor Immunity to Resistance

View Full Paper
Ask AI
Bookmark
Share

Authors

MBMegha BudhwaniThe University of QueenslandRMRoberta MazzieriThe University of MelbourneRDRiccardo DolcettiThe University of Queensland

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Budhwani et al. (2018) studied this question.

synapsesocial.com/papers/69d6c56ce328128020aa83c8https://doi.org/10.3389/fonc.2018.00322
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1IFN-α Directly Promotes Programmed Cell Death-1 Transcription and Limits the Duration of T Cell-Mediated Immunity2011 · 335 citations
  2. 2Intercellular transmission of the unfolded protein response promotes survival and drug resistance in cancer cells2017 · 112 citations